M. Vanthuyne

发表

Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population.

Jane Worthington, T. Radstake, Javier Martín, 2011, Rheumatology.

Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort.

F. Spertini, A. Gabrielli, D. Rimar, 2019, Rheumatology.

Hand radiological damage in systemic sclerosis: comparison with a control group and clinical and functional correlations.

F. Houssiau, R. Westhovens, J. Malghem, 2011, Seminars in arthritis and rheumatism.

High prevalence of occupational exposure to solvents or silica in male systemic sclerosis patients: a Belgian cohort analysis

F. Houssiau, B. Nemery, D. Blockmans, 2018, Clinical Rheumatology.

Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis.

J. Demoulin, J. Lennartsson, F. Houssiau, 2009, Arthritis and rheumatism.

Correction: Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy

Annette Lee, P. Gregersen, R. Ophoff, 2011, PLoS Genetics.

Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders: A retrospective cohort study.

C. Bonroy, W. Wuyts, F. Houssiau, 2021, Seminars in arthritis and rheumatism.

Identification of novel genetic markers associated with the clinical phenotypes of systemic sclerosis through a genome wide association strategy

Annette Lee, P. Gregersen, R. Ophoff, 2010, Journal of Translational Medicine.

Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study.

R. Caporali, P. Carreira, U. Walker, 2013, Clinical and experimental rheumatology.

Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database

F. Mendoza, J. D. de Vries-Bouwstra, M. Cerinic, 2020, Arthritis Research & Therapy.

Comparison of the disease activity score and the revised EUSTAR activity index in diffuse cutaneous systemic sclerosis patients.

F. Houssiau, B. Lauwerys, M. Vanthuyne, 2020, Clinical and experimental rheumatology.

Over-representation of construction-related occupations in male patients with systemic sclerosis

F. Houssiau, V. Smith, F. de Keyser, 2008, Annals of the rheumatic diseases.

Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort.

M. Boubaya, F. Mendoza, J. D. de Vries-Bouwstra, 2022, The Lancet. Rheumatology.

Two years follow-up of an open-label pilot study of treatment with rituximab in patients with early diffuse cutaneous systemic sclerosis

M. de Pauw, F. Houssiau, D. Blockmans, 2018, Acta clinica Belgica.

The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis

T. Radstake, A. Herrick, R. Ríos-Fernandez, 2011, Genes and Immunity.

Systemic sclerosis: state of the art on clinical practice guidelines

J. D. de Vries-Bouwstra, Matthias Schneider, G. Burmester, 2018, RMD Open.

Correction: Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy

Annette Lee, P. Gregersen, R. Ophoff, 2011, PLoS Genetics.

Correction: Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy

Annette Lee, P. Gregersen, R. Ophoff, 2011, PLoS Genetics.

Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy

Annette Lee, P. Gregersen, R. Ophoff, 2011, PLoS genetics.

University of Groningen Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy Gorlova,

Rajan, Arnett, Annette Lee, 2011 .

Hypercalcemia Heralding Pneumocystis jirovecii Pneumonia in an HIV-Seronegative Patient with Diffuse Cutaneous Systemic Sclerosis

J. Mairesse, M. Vanthuyne, J. Marot, 2019, Mycopathologia.

Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis

Jane Worthington, M. Mayes, R. Scorza, 2010, Annals of the rheumatic diseases.

The association of illness perceptions with physical and mental health in systemic sclerosis patients: an exploratory study.

F. Houssiau, D. Blockmans, R. Westhovens, 2012, Musculoskeletal care.

The Belgian Systemic Sclerosis Cohort: Correlations Between Disease Severity Scores, Cutaneous Subsets, and Autoantibody Profile

F. Houssiau, D. Blockmans, R. Westhovens, 2012, The Journal of Rheumatology.

A pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulses and oral low-dose glucocorticoids in severe early systemic sclerosis.

E. Coche, F. Houssiau, D. Blockmans, 2007, Clinical and experimental rheumatology.

Efficacy of golimumab in Belgian patients with active rheumatoid arthritis despite treatment with non-biologic disease-modifying anti-rheumatic drugs: sub-analysis of the GO-MORE study

P. Geusens, M. Malaise, P. Durez, 2017, Acta clinica Belgica.

Validation of a manual ability questionnaire in patients with systemic sclerosis.

J. Thonnard, F. Houssiau, R. Westhovens, 2009, Arthritis and rheumatism.

Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

M. L. Lopes, A. Gabrielli, U. Müller-Ladner, 2010, Annals of the rheumatic diseases.

Late Skin Fibrosis in Systemic Sclerosis: A Study from the EUSTAR Cohort.

A. Gabrielli, D. Khanna, E. Hachulla, 2022, Rheumatology.

Flemish network on rare connective tissue diseases (CTD): patient pathways in systemic sclerosis. First steps taken

M. de Pauw, P. de Haes, V. Sabato, 2023, Acta clinica Belgica.

Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: an EUSTAR database analysis.

J. D. de Vries-Bouwstra, A. Gabrielli, C. Campochiaro, 2022, Rheumatology.